Analgesics: Page 5

Fewer opioids prescribed in 3rd-molar surgeries with bupivacaine

By Melissa Busch

Oral surgeons prescribed 59% fewer total opioids for patients who received liposomal bupivacaine (LB) during third-molar extractions than for those who did not receive LB, according to a study published on February 22 in the Journal of Oral and Maxillofacial Surgery.

March 2, 2021

State of U.S. oral health: 4 dental trends to watch

By Theresa Pablos

The U.S. spent $135 billion on dental services in 2018, according to a March 2 report from the U.S. Centers for Disease Control and Prevention on the health status of the nation. The whopping sum was just one of several dental trends outlined in the report.

March 1, 2021

NYU receives $2.9M for oral cancer pain research

By DrBicuspid.com staff writers

The National Institute of Dental and Craniofacial Research has awarded researchers at New York University (NYU) College of Dentistry a five-year, $2.9 million grant to investigate oral cancer pain treatment.

January 31, 2021

Podcast: Acetaminophen, supplements, and more -- the effects on your dental patients

By Kevin Henry

There is a lot to know about the everyday drugs and medications your dental patients take, including ones they may not think to tell you about, such as acetaminophen and supplements. In this podcast, dental pharmacology expert Tom Viola, RPh, shares his thoughts on the dangers that could be lurking and what dentists and dental team members need to know.

December 22, 2020

Top 5 stories of 2020 on anesthesia and pain management

By Melissa Busch

Anesthesia use and pain control are major concerns in dentistry. DrBicuspid.com always tries to bring you the most cutting-edge stories about these topics, and those that discussed drug interactions and potential medication abuse resonated with you the most this year.

December 13, 2020

Orofacial Therapeutics honored as pain solution provider

By DrBicuspid.com staff writers

Orofacial Therapeutics has been named a top 10 pain solution provider by MedTech Outlook, a medical trade magazine.

December 6, 2020

Podcast: How cannabis affects your patients and their dental treatment

By Kevin Henry

With more and more states legalizing medicinal and/or recreational marijuana, Tom Viola, RPh, thinks now is a great time to discuss cannabis and pain control in the dental practice. You may think you know how cannabis affects your dental patients, but Viola has some new information that could surprise you.

November 19, 2020

Podcast: Let's talk about codeine and pain control for your patients

By Kevin Henry

Codeine is often viewed as a good alternative for pain control for your patients, but what do you really need to know about it and what health risks should you keep in mind? Tom Viola, RPh, shares his thoughts on what you and your team need to know about codeine in this short podcast.

November 9, 2020

Podcast: What you need to know about ibuprofen and pregnancy

By Kevin Henry

Some additional discussion has come about in recent weeks regarding the potential danger of taking ibuprofen during pregnancy. In this short podcast, Tom Viola, RPh, discusses some big changes and what you need to know if you're thinking about suggesting ibuprofen to your female patients or coworkers.

November 2, 2020

NYU College of Dentistry awarded $3.9M grant focusing on chronic pain treatment

By DrBicuspid.com staff writers

Researchers at New York University (NYU) College of Dentistry have been awarded a $3.9 million grant from the U.S. National Institute of Dental and Craniofacial Research to study chronic pain treatment.

September 27, 2020

FDA awards $1.5M grant to ADA Science & Research Institute

By DrBicuspid.com staff writers

The ADA announced that the U.S. Food and Drug Administration (FDA) has awarded a three-year, $1.5 million grant to the ADA Science & Research Institute in collaboration with the University of Pittsburgh to develop a clinical practice guideline for the management of acute pain in dentistry, with a focus on the role of opioids.

August 27, 2020

What every dentist and team member should know about these 2 drugs

By Tom Viola, RPh

A new U.S. Food and Drug Administration (FDA) warning regarding gabapentin and pregabalin recently caught the eye of Tom Viola, RPh. Now, he has some advice to share with DrBicuspid.com readers on why the warning is something they should understand and heed.

June 30, 2020

Previous Page

Page 5 of 43

Next Page